RCM
AZN icon

RNC Capital Management’s AstraZeneca AZN Stock Holding History

RNC Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.07M Sell
33,018
-228
-0.7% -$40K 0.28% 50
2025
Q3 		$5.1M Buy
33,246
+3,107
+10% +$470K 0.23% 58
2025
Q2 		$4.21M Buy
30,139
+281
+0.9% +$39.4K 0.2% 61
2025
Q1 		$4.39M Buy
29,858
+1,020
+4% +$148K 0.22% 56
2024
Q4 		$3.78M Buy
28,838
+9,103
+46% +$1.27M 0.2% 59
2024
Q3 		$3.08M Hold
19,735
– – 0.17% 66
2024
Q2 		$3.08M Buy
19,735
+1,598
+9% +$240K 0.17% 66
2024
Q1 		$2.46M Sell
18,137
-339
-2% -$44.9K 0.14% 69
2023
Q4 		$2.49M Buy
18,476
+527
+3% +$68.5K 0.15% 64
2023
Q3 		$2.43M Sell
17,949
-347
-2% -$47.4K 0.15% 66
2023
Q2 		$2.62M Sell
18,296
-28,792
-61% -$4.24M 0.14% 79
2023
Q1 		$6.54M Sell
47,088
-2,225
-5% -$299K 0.37% 41
2022
Q4 		$6.69M Sell
49,313
-1,155
-2% -$145K 0.37% 43
2022
Q3 		$5.54M Sell
50,468
-202
-0.4% -$25.6K 0.35% 45
2022
Q2 		$6.7M Buy
50,670
+7,841
+18% +$1.03M 0.38% 41
2022
Q1 		$5.68M Buy
42,829
+16,401
+62% +$1.97M 0.29% 58
2021
Q4 		$3.08M Sell
26,428
-9,857
-27% -$1.16M 0.15% 81
2021
Q3 		$4.36M Buy
36,285
+22,225
+158% +$2.59M 0.23% 67
2021
Q2 		$1.68M Buy
+14,060
New +$1.54M 0.09% 93

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RNC Capital Management's AZN Position: Q4 2025 in Review

RNC Capital Management reduced its AstraZeneca (AZN) stake by 0.69% in Q4 2025, selling an estimated $40K and leaving 33,018 shares worth $6.07M. The position accounts for 0.28% of the portfolio, ranked #50.

RNC Capital Management first reported a position in AZN in Q2 2021 and has held it in 19 quarters since. The position peaked at $6.7M in Q2 2022. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • RNC Capital Management held 33,018 shares of AstraZeneca worth $6.07M as of Q4 2025.
  • RNC Capital Management sold 228 AstraZeneca shares in Q4 2025, an estimated $40K.
  • AstraZeneca made up 0.28% of RNC Capital Management's portfolio in Q4 2025, its #50 holding.
  • RNC Capital Management first reported a position in AstraZeneca in Q2 2021 and has held it in 19 quarters since.
  • RNC Capital Management's AstraZeneca position peaked at $6.7M in Q2 2022.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.